Technology transfer of a dried blood virus neutralization assay to a GAVI-eligible country
Evangeline Obodai, View ORCID ProfileJonne Terstappen, Jude Y. Mensah, Anouk Versnel, Comfort N. Antwi, Louis J. Bont, Daniela Cianci, Eveline M. Delemarre, John K. Odoom, Peter M. van de Ven, Natalie I. Mazur
doi: https://doi.org/10.1101/2024.07.23.24310857
Evangeline Obodai
1Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana
PhDJonne Terstappen
2Department of Pediatric Infectious Diseases and Immunology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
3Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
MDJude Y. Mensah
1Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana
BScAnouk Versnel
3Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
MScComfort N. Antwi
1Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana
MPhilLouis J. Bont
2Department of Pediatric Infectious Diseases and Immunology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
4ReSViNET Foundation, Zeist, The Netherlands
PhDDaniela Cianci
5Julius Center for Health Sciences and Primary Care, Department of Data Science & Biostatistics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
PhDEveline M. Delemarre
3Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
PhDJohn K. Odoom
1Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana
PhDPeter M. van de Ven
5Julius Center for Health Sciences and Primary Care, Department of Data Science & Biostatistics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
PhDNatalie I. Mazur
2Department of Pediatric Infectious Diseases and Immunology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
3Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
PhDData availability
On reasonable request to the corresponding authors, the data can be shared with publication.
Posted July 24, 2024.
Technology transfer of a dried blood virus neutralization assay to a GAVI-eligible country
Evangeline Obodai, Jonne Terstappen, Jude Y. Mensah, Anouk Versnel, Comfort N. Antwi, Louis J. Bont, Daniela Cianci, Eveline M. Delemarre, John K. Odoom, Peter M. van de Ven, Natalie I. Mazur
medRxiv 2024.07.23.24310857; doi: https://doi.org/10.1101/2024.07.23.24310857
Technology transfer of a dried blood virus neutralization assay to a GAVI-eligible country
Evangeline Obodai, Jonne Terstappen, Jude Y. Mensah, Anouk Versnel, Comfort N. Antwi, Louis J. Bont, Daniela Cianci, Eveline M. Delemarre, John K. Odoom, Peter M. van de Ven, Natalie I. Mazur
medRxiv 2024.07.23.24310857; doi: https://doi.org/10.1101/2024.07.23.24310857
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (190)
- Cardiovascular Medicine (2835)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12540)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4418)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2843)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4171)
- Nursing (220)
- Nutrition (615)
- Oncology (2198)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (481)
- Public and Global Health (6760)
- Radiology and Imaging (1486)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (472)
- Toxicology (57)
- Transplantation (200)
- Urology (173)